GEN-001 Plus Pembrolizumab for Patients With Advanced Refractory Biliary Tract Cancer

Clinical trial NCT05998447 · TERMINATED

Trial details

NCT number: NCT05998447
Sponsor: Genome & Company
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Biliary Tract Cancer

Start date: 2023-09-18
Primary completion: 2024-11-26
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.